Nothing Special   »   [go: up one dir, main page]
create a website
Pharmaceutical Price Controls and Entry Strategies. (2007). Kyle, Margaret.
In: The Review of Economics and Statistics.
RePEc:tpr:restat:v:89:y:2007:i:1:p:88-99.

Full description at Econpapers || Download paper

Cited: 146

Citations received by this document

Cites: 0

References cited by this document

Cocites: 0

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

  1. A toolkit for setting and evaluating price floors. (2024). Hernández, Carlos Eduardo ; Cantillo-Cleves, Santiago.
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:232:y:2024:i:c:s0047272724000203.

    Full description at Econpapers || Download paper

  2. The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis. (2024). Hollis, Aidan ; Grootendorst, Paul ; Guh, Daphne P ; Zhang, Wei ; Anis, Aslam H.
    In: Health Policy.
    RePEc:eee:hepoli:v:144:y:2024:i:c:s0168851024000745.

    Full description at Econpapers || Download paper

  3. A toolkit for setting and evaluating price floors. (2024). Hernández, Carlos Eduardo ; Cantillo-Cleves, Santiago.
    In: University of California at San Diego, Economics Working Paper Series.
    RePEc:cdl:ucsdec:qt0209r817.

    Full description at Econpapers || Download paper

  4. Pharmaceutical regulation under market integration through parallel trade. (2023). Birg, Laura.
    In: Canadian Journal of Economics/Revue canadienne d'économique.
    RePEc:wly:canjec:v:56:y:2023:i:4:p:1322-1346.

    Full description at Econpapers || Download paper

  5. Accelerating Innovation Ecosystems: The Promise and Challenges of Regional Innovation Engines. (2023). Williams, Heidi ; Stern, Scott ; Murray, Fiona ; Guzman, Jorge.
    In: NBER Chapters.
    RePEc:nbr:nberch:14874.

    Full description at Econpapers || Download paper

  6. Can selective price controls fight off inflation? Lessons from milk products in Croatia. (2023). Ili, Ivan ; Mui, Ivan.
    In: Working Papers.
    RePEc:hnb:wpaper:71.

    Full description at Econpapers || Download paper

  7. The price of cost-effectiveness thresholds. (2023). Straume, Odd Rune ; Dalen, Dag Morten ; Brekke, Kurt R.
    In: Discussion Paper Series in Economics.
    RePEc:hhs:nhheco:2023_004.

    Full description at Econpapers || Download paper

  8. Rent Control, Market Segmentation, and Misallocation: Causal Evidence from a Large-Scale Policy Intervention. (2023). Kholodilin, Konstantin A ; Michelsen, Claus ; Mense, Andreas.
    In: Journal of Urban Economics.
    RePEc:eee:juecon:v:134:y:2023:i:c:s0094119022000894.

    Full description at Econpapers || Download paper

  9. The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets. (2023). Straume, Odd Rune ; Dalen, Dag Morten ; Brekke, Kurt R.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:90:y:2023:i:c:s0167629623000553.

    Full description at Econpapers || Download paper

  10. The same old medicine but cheaper: The impact of patent expiry on physicians’ prescribing behaviour. (2022). Lippi Bruni, Matteo ; Mammi, Irene ; Fiorentini, Gianluca.
    In: Journal of Economic Behavior & Organization.
    RePEc:eee:jeborg:v:204:y:2022:i:c:p:37-68.

    Full description at Econpapers || Download paper

  11. Which policies for vaccine innovation and delivery in Europe?. (2022). Dewatripont, Mathias.
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:84:y:2022:i:c:s0167718722000340.

    Full description at Econpapers || Download paper

  12. Incentives for pharmaceutical innovation: What’s working, what’s lacking. (2022). Kyle, Margaret K.
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:84:y:2022:i:c:s0167718722000261.

    Full description at Econpapers || Download paper

  13. The effect of patented drug price on the share of new medicines across OECD countries. (2022). Grootendorst, Paul ; Spicer, Oliver.
    In: Health Policy.
    RePEc:eee:hepoli:v:126:y:2022:i:8:p:795-801.

    Full description at Econpapers || Download paper

  14. Which Policies for Vaccine Innovation and Delivery in Europe ?. (2022). Dewatripont, Mathias.
    In: Working Papers ECARES.
    RePEc:eca:wpaper:2013/343280.

    Full description at Econpapers || Download paper

  15. INNOVATION AND DIFFUSION OF MEDICAL TREATMENT. (2021). Papageorge, Nicholas ; Hamilton, Barton H ; Miller, Robert A ; Hincapie, Andres.
    In: International Economic Review.
    RePEc:wly:iecrev:v:62:y:2021:i:3:p:953-1009.

    Full description at Econpapers || Download paper

  16. Targeted Price Controls on Supermarket Products. (2021). Cavallo, Alberto ; Aparicio, Diego.
    In: The Review of Economics and Statistics.
    RePEc:tpr:restat:v:103:y:2021:i:1:p:60-71.

    Full description at Econpapers || Download paper

  17. Rare Diseases Require Support Too. (2021). Das, Neelima ; Pingali, Viswanath .
    In: Vikalpa: The Journal for Decision Makers.
    RePEc:sae:vikjou:v:46:y:2021:i:2:p:129-134.

    Full description at Econpapers || Download paper

  18. Collusion in the US Generic Drug Industry. (2021). Lasio, Laura ; Fabiilli, Christopher Anthony ; Clark, Robert.
    In: Working Paper.
    RePEc:qed:wpaper:1474.

    Full description at Econpapers || Download paper

  19. How Does Regulation Impact Strategic Repositioning by Firms Across Submarkets? Evidence from the Indian Pharmaceutical Industry. (2021). Pennings, Enrico ; Chatterjee, Chirantan ; Anurag, Priyatam ; Bhaskarabhatla, Ajay.
    In: Strategy Science.
    RePEc:inm:orstsc:v:6:y:2021:i:3:p:209-227.

    Full description at Econpapers || Download paper

  20. Product patents and access to innovative medicines. (2021). Watal, Jayashree ; Dai, Rong.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:291:y:2021:i:c:s027795362100811x.

    Full description at Econpapers || Download paper

  21. On the Effect of Parallel Trade on Manufacturers and Retailers Profits in the Pharmaceutical Sector. (2020). Sæthre, Morten ; Dubois, Pierre ; Sathre, Morten.
    In: Econometrica.
    RePEc:wly:emetrp:v:88:y:2020:i:6:p:2503-2545.

    Full description at Econpapers || Download paper

  22. Innovation for and from emerging countries: a closer look at the antecedents of trickle-down and reverse innovation. (2020). Rubera, Gaia ; Giannetti, Verdiana.
    In: Journal of the Academy of Marketing Science.
    RePEc:spr:joamsc:v:48:y:2020:i:5:d:10.1007_s11747-019-00669-3.

    Full description at Econpapers || Download paper

  23. Stakeholder Orientation and Market Impact: Evidence from India. (2020). Chatterjee, Chirantan ; Bhaskarabhatla, Ajay ; Adbi, Arzi.
    In: Journal of Business Ethics.
    RePEc:kap:jbuset:v:161:y:2020:i:2:d:10.1007_s10551-018-3919-x.

    Full description at Econpapers || Download paper

  24. Umbrella branding in pharmaceutical markets. (2020). Suppliet, Moritz.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:73:y:2020:i:c:s0167629619303856.

    Full description at Econpapers || Download paper

  25. Optimal price regulations in international pharmaceutical markets with generic competition. (2020). Saggi, Kamal ; Geng, Difei.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:71:y:2020:i:c:s0167629619303844.

    Full description at Econpapers || Download paper

  26. How to address medicines shortages: Findings from a cross-sectional study of 24 countries. (2020). Fischer, Stefan ; Vogler, Sabine.
    In: Health Policy.
    RePEc:eee:hepoli:v:124:y:2020:i:12:p:1287-1296.

    Full description at Econpapers || Download paper

  27. Licensing Life-Saving Drugs for Developing Countries: Evidence from the Medicines Patent Pool. (2020). Schankerman, Mark ; Galasso, Alberto.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:15544.

    Full description at Econpapers || Download paper

  28. Regulating Innovation with Uncertain Quality: Information, Risk, and Access in Medical Devices. (2020). Town, Robert J ; Grennan, Matthew.
    In: American Economic Review.
    RePEc:aea:aecrev:v:110:y:2020:i:1:p:120-61.

    Full description at Econpapers || Download paper

  29. Product patents and access to innovative medicines in a post-trips-era. (2019). Dai, Rong ; Watal, Jayashree.
    In: WTO Staff Working Papers.
    RePEc:zbw:wtowps:ersd201905.

    Full description at Econpapers || Download paper

  30. On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector. (2019). Sæthre, Morten ; Dubois, Pierre.
    In: TSE Working Papers.
    RePEc:tse:wpaper:32393.

    Full description at Econpapers || Download paper

  31. Launch of a product and patents: evidence from the US cardiovascular pharmaceutical sector. (2019). Giorgietti, Maria Letizia ; di Iorio, Francesca.
    In: DEM Working Papers Series.
    RePEc:pav:demwpp:demwp0169.

    Full description at Econpapers || Download paper

  32. The Single Market in Pharmaceuticals. (2019). Kyle, Margaret K.
    In: Review of Industrial Organization.
    RePEc:kap:revind:v:55:y:2019:i:1:d:10.1007_s11151-019-09694-6.

    Full description at Econpapers || Download paper

  33. Fair prices for medicines? Exploring competent authorities’ and public payers’ preferences on pharmaceutical policies. (2019). Vogler, Sabine.
    In: Empirica.
    RePEc:kap:empiri:v:46:y:2019:i:3:d:10.1007_s10663-019-09446-5.

    Full description at Econpapers || Download paper

  34. Non-Tariff Barriers and Bargaining in Generic Pharmaceuticals. (2019). Ganapati, Sharat ; Mckibbin, Rebecca .
    In: Working Papers.
    RePEc:geo:guwopa:gueconwpa~18-18-23.

    Full description at Econpapers || Download paper

  35. Comparing approval procedures for new drugs. (2019). Jelovac, Izabela ; Houy, Nicolas.
    In: The World Economy.
    RePEc:bla:worlde:v:42:y:2019:i:5:p:1598-1619.

    Full description at Econpapers || Download paper

  36. Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals. (2018). Lasio, Laura ; Dubois, Pierre.
    In: TSE Working Papers.
    RePEc:tse:wpaper:27919.

    Full description at Econpapers || Download paper

  37. The TRIPS Article 31 Tug of War Developing Country Compulsory Licensing of Pharmaceutical Patents and Developed Country Retaliation. (2018). Volman, Lucas.
    In: LawArXiv.
    RePEc:osf:lawarx:6cxaj.

    Full description at Econpapers || Download paper

  38. Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets. (2018). Kyle, Margaret K.
    In: Review of Industrial Organization.
    RePEc:kap:revind:v:53:y:2018:i:1:d:10.1007_s11151-018-9639-7.

    Full description at Econpapers || Download paper

  39. The Impact of the Entry of Biosimilars: Evidence from Europe. (2018). Stern, Scott ; Scott, Fiona M.
    In: Review of Industrial Organization.
    RePEc:kap:revind:v:53:y:2018:i:1:d:10.1007_s11151-018-9630-3.

    Full description at Econpapers || Download paper

  40. Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals. (2018). Snyder, Christopher ; Kremer, Michael.
    In: Review of Industrial Organization.
    RePEc:kap:revind:v:53:y:2018:i:1:d:10.1007_s11151-018-9621-4.

    Full description at Econpapers || Download paper

  41. Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals. (2018). Kremer, Michael ; Snyder, Christopher.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:12751.

    Full description at Econpapers || Download paper

  42. On the Effect of Parallel Trade on Manufacturers and Retailers Profits in the Pharmaceutical Sector. (2018). Sæthre, Morten ; Dubois, Pierre.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:12649.

    Full description at Econpapers || Download paper

  43. Launch Decisions of Pharmaceutical Companies. (2017). Civan, Abdulkadir ; Maloney, Michael .
    In: Journal of Economics and Financial Analysis.
    RePEc:trp:01jefa:jefa0008.

    Full description at Econpapers || Download paper

  44. Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs. (2017). Williams, Heidi ; Kyle, Margaret.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:23068.

    Full description at Econpapers || Download paper

  45. A Deeper Analysis on Pharmaceutical Submarket Concentration: the US market in 1987-1998. (2017). Giorgetti, Maria Letizia ; di Iorio, Francesca.
    In: Departmental Working Papers.
    RePEc:mil:wpdepa:2017-02.

    Full description at Econpapers || Download paper

  46. Drug innovation, price controls, and parallel trade. (2017). Reverberi, Pierfrancesco ; Matteucci, Giorgio.
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:17:y:2017:i:2:d:10.1007_s10754-016-9205-5.

    Full description at Econpapers || Download paper

  47. On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector.. (2017). Sæthre, Morten ; Dubois, Pierre ; Sathre, Morten.
    In: Discussion Paper Series in Economics.
    RePEc:hhs:nhheco:2018_003.

    Full description at Econpapers || Download paper

  48. International effects of national regulations: External reference pricing and price controls. (2017). Saggi, Kamal ; Geng, Difei .
    In: Journal of International Economics.
    RePEc:eee:inecon:v:109:y:2017:i:c:p:68-84.

    Full description at Econpapers || Download paper

  49. Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets. (2017). Kyle, Margaret K.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:12420.

    Full description at Econpapers || Download paper

  50. Squeezing the Last Drop Out of Your Suppliers: An Empirical Study of Market-Based Purchasing Policies for Generic Pharmaceuticals. (2017). Bergman, Mats A ; Rudholm, Niklas ; Granlund, David.
    In: Oxford Bulletin of Economics and Statistics.
    RePEc:bla:obuest:v:79:y:2017:i:6:p:969-996.

    Full description at Econpapers || Download paper

  51. Bargaining over Entry with a Compulsory License Deadline: Price Spillovers and Surplus Expansion. (2017). Saggi, Kamal ; Bond, Eric.
    In: American Economic Journal: Microeconomics.
    RePEc:aea:aejmic:v:9:y:2017:i:1:p:31-62.

    Full description at Econpapers || Download paper

  52. External reference pricing and the choice of country baskets and pricing rules. (2016). Birg, Laura.
    In: Center for European, Governance and Economic Development Research Discussion Papers.
    RePEc:zbw:cegedp:279.

    Full description at Econpapers || Download paper

  53. Access to Medicines and European Market Integration. (2016). Rungi, Armando ; Pammolli, Fabio.
    In: Working Papers.
    RePEc:ial:wpaper:01/2016.

    Full description at Econpapers || Download paper

  54. Squeezing the last drop out of your suppliers: an empirical study of market-based purchasing policies for generic pharmaceuticals. (2016). Bergman, Mats A ; Granlund, David ; Rudholm, Niklas.
    In: Umeå Economic Studies.
    RePEc:hhs:umnees:0921.

    Full description at Econpapers || Download paper

  55. Squeezing the last drop out of your suppliers: an empirical study of market-based purchasing policies for generic pharmaceuticals. (2016). Rudholm, Niklas ; Granlund, David ; Bergman, Mats .
    In: HUI Working Papers.
    RePEc:hhs:huiwps:0116.

    Full description at Econpapers || Download paper

  56. Patents and the global diffusion of new drugs. (2016). Cockburn, Iain ; Schankerman, Mark ; Lanjouw, Jean O.
    In: LSE Research Online Documents on Economics.
    RePEc:ehl:lserod:65415.

    Full description at Econpapers || Download paper

  57. Reference pricing with endogenous generic entry. (2016). Straume, Odd Rune ; Canta, Chiara ; Brekke, Kurt.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:50:y:2016:i:c:p:312-329.

    Full description at Econpapers || Download paper

  58. Late-stage pharmaceutical R&D and pricing policies under two-stage regulation. (2016). Pertile, Paolo ; Forster, Martin ; Jobjornsson, Sebastian ; Burman, Carl-Fredrik .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:50:y:2016:i:c:p:298-311.

    Full description at Econpapers || Download paper

  59. The Impact of Governmental Policy on R&D Projects in the Pharmaceutical Industry. (2015). Baftijari, Agon ; Stojchevska, Ivana.
    In: Proceedings of the ENTRENOVA - ENTerprise REsearch InNOVAtion Conference (2015), Kotor, Montengero.
    RePEc:zbw:entr15:183633.

    Full description at Econpapers || Download paper

  60. Parallel trade and reimbursement regulation. (2015). Birg, Laura.
    In: Center for European, Governance and Economic Development Research Discussion Papers.
    RePEc:zbw:cegedp:253.

    Full description at Econpapers || Download paper

  61. Late-Stage Pharmaceutical R & D and Pricing Policies under Two-Stage Regulation. (2015). Pertile, Paolo ; Forster, Martin ; Jobjornsson, Sebastian ; Burman, Carl-Fredrik .
    In: Discussion Papers.
    RePEc:yor:yorken:15/16.

    Full description at Econpapers || Download paper

  62. Drug Launch Timing and International Reference Pricing. (2015). Jelovac, Izabela ; Houy, Nicolas.
    In: Health Economics.
    RePEc:wly:hlthec:v:24:y:2015:i:8:p:978-989.

    Full description at Econpapers || Download paper

  63. Regulation effects on the adoption of new medicines. (2015). Costa-Font, Joan ; costa -Font, Joan ; Varol, Nebibe ; McGuire, Alistair.
    In: Empirical Economics.
    RePEc:spr:empeco:v:49:y:2015:i:3:p:1101-1121.

    Full description at Econpapers || Download paper

  64. Price regulation and parallel imports of pharmaceuticals. (2015). Straume, Odd Rune ; Brekke, Kurt ; Holms, Tor Helge.
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:129:y:2015:i:c:p:92-105.

    Full description at Econpapers || Download paper

  65. The consumer welfare implications of governmental policies and firm strategy in markets for medicines. (2015). Kubo, Kensuke ; Pingali, Viswanath ; Chatterjee, Chirantan.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:44:y:2015:i:c:p:255-273.

    Full description at Econpapers || Download paper

  66. Price Regulation and Parallel Imports of Pharmaceuticals. (2015). Straume, Odd Rune ; Brekke, Kurt ; Holms, Tor Helge.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_5469.

    Full description at Econpapers || Download paper

  67. Vergleichbarkeit internationaler Arzneimittelpreise. (2015). Suppliet, Moritz ; Mahlich, Jörg ; Moritz, Suppliet ; Jorn, Sindern ; Jorg, Mahlich .
    In: Perspektiven der Wirtschaftspolitik.
    RePEc:bpj:pewipo:v:16:y:2015:i:2:p:164-172:n:5.

    Full description at Econpapers || Download paper

  68. The welfare impact of parallel imports: A structural approach applied to the German market for oral antidiabetics. (2014). Suppliet, Moritz ; Herr, Annika ; Duso, Tomaso.
    In: Annual Conference 2014 (Hamburg): Evidence-based Economic Policy.
    RePEc:zbw:vfsc14:100298.

    Full description at Econpapers || Download paper

  69. The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-diabetics. (2014). Suppliet, Moritz ; Herr, Annika ; Duso, Tomaso.
    In: Health, Econometrics and Data Group (HEDG) Working Papers.
    RePEc:yor:hectdg:14/09.

    Full description at Econpapers || Download paper

  70. THE WELFARE IMPACT OF PARALLEL IMPORTS: A STRUCTURAL APPROACH APPLIED TO THE GERMAN MARKET FOR ORAL ANTI‐DIABETICS. (2014). Suppliet, Moritz ; Herr, Annika ; Duso, Tomaso.
    In: Health Economics.
    RePEc:wly:hlthec:v:23:y:2014:i:9:p:1036-1057.

    Full description at Econpapers || Download paper

  71. Pharmaceutical regulation in Europe and its impact on corporate R&D. (2014). Mahlich, Jörg ; Eger, Stephan .
    In: Health Economics Review.
    RePEc:spr:hecrev:v:4:y:2014:i:1:p:1-9:10.1186/s13561-014-0023-5.

    Full description at Econpapers || Download paper

  72. Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs. (2014). Brekke, Kurt ; Holms, Tor ; Dalen, Dag .
    In: The European Journal of Health Economics.
    RePEc:spr:eujhec:v:15:y:2014:i:9:p:937-951.

    Full description at Econpapers || Download paper

  73. Price Regulation and Parallel Imports of Pharmaceuticals. (2014). Straume, Odd Rune ; Brekke, Kurt ; Holms, Tor Helge.
    In: NIPE Working Papers.
    RePEc:nip:nipewp:01/2014.

    Full description at Econpapers || Download paper

  74. Intellectual Property Rights and Access to Innovation: Evidence from TRIPS. (2014). Kyle, Margaret ; Qian, YI.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:20799.

    Full description at Econpapers || Download paper

  75. Regulation of the Pharmaceutical-Biotechnology Industry. (2014). Keuffel, Eric ; Danzon, Patricia M..
    In: NBER Chapters.
    RePEc:nbr:nberch:12572.

    Full description at Econpapers || Download paper

  76. Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals. (2014). Lasio, Laura ; Dubois, Pierre.
    In: IDEI Working Papers.
    RePEc:ide:wpaper:27918.

    Full description at Econpapers || Download paper

  77. Price Regulation and Parallel Imports of Pharmaceuticals.. (2014). Straume, Odd Rune ; Brekke, Kurt ; Holms, Tor Helge.
    In: Discussion Paper Series in Economics.
    RePEc:hhs:nhheco:2014_001.

    Full description at Econpapers || Download paper

  78. Drug approval decision times, international reference pricing and strategic launches of new drugs. (2014). Jelovac, Izabela ; Houy, Nicolas.
    In: Working Papers.
    RePEc:hal:wpaper:halshs-01072741.

    Full description at Econpapers || Download paper

  79. Drug approval decision times, international reference pricing and strategic launches of new drugs. (2014). Jelovac, Izabela ; Houy, Nicolas.
    In: Working Papers.
    RePEc:gat:wpaper:1425.

    Full description at Econpapers || Download paper

  80. Public Policy: Object of Choice or Emergent Phenomena? Learning from the Implementation of the Medical Reimbursement Act in Poland. (2014). Podemska-Mikluch, Marta .
    In: Advances in Austrian Economics.
    RePEc:eme:aaeczz:s1529-213420140000018005.

    Full description at Econpapers || Download paper

  81. Price regulation and relative delays in generic drug adoption. (2014). Costa-i-Font, Joan ; McGuire, Alistair ; Varol, Nebibe ; Costa-Font, Joan ; costa -Font, Joan .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:38:y:2014:i:c:p:1-9.

    Full description at Econpapers || Download paper

  82. Pharmaceutical innovation and parallel trade. (2014). Valletti, Tommaso ; Bennato, Anna Rita .
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:33:y:2014:i:c:p:83-92.

    Full description at Econpapers || Download paper

  83. Compulsory licensing, price controls, and access to patented foreign products. (2014). Saggi, Kamal ; Bond, Eric.
    In: Journal of Development Economics.
    RePEc:eee:deveco:v:109:y:2014:i:c:p:217-228.

    Full description at Econpapers || Download paper

  84. The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-Diabetics. (2014). Suppliet, Moritz ; Herr, Annika ; Duso, Tomaso.
    In: Discussion Papers of DIW Berlin.
    RePEc:diw:diwwpp:dp1373.

    Full description at Econpapers || Download paper

  85. Identifying Industry Margins with Unobserved Price Constraints: Structural Estimation on Pharmaceuticals. (2014). Lasio, Laura ; Dubois, Pierre.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:9881.

    Full description at Econpapers || Download paper

  86. Parallel trade, price regulation, and investment incentives. (2014). Reverberi, Pierfrancesco ; Matteucci, Giorgio.
    In: DIAG Technical Reports.
    RePEc:aeg:report:2014-16.

    Full description at Econpapers || Download paper

  87. .

    Full description at Econpapers || Download paper

  88. .

    Full description at Econpapers || Download paper

  89. .

    Full description at Econpapers || Download paper

  90. .

    Full description at Econpapers || Download paper

  91. THE DETERMINANTS OF PRICING IN PHARMACEUTICALS: ARE US PRICES REALLY SO HIGH?. (2013). Jimenez-Martin, Sergi ; Cabrales, Antonio ; JimenezMartin, Sergi .
    In: Health Economics.
    RePEc:wly:hlthec:v:22:y:2013:i:11:p:1377-1397.

    Full description at Econpapers || Download paper

  92. The dynamics of pharmaceutical regulation and R&D investments. (2013). Pertile, Paolo ; moretto, michele ; LEVAGGI, ROSELLA.
    In: Working Papers.
    RePEc:ver:wpaper:13/2013.

    Full description at Econpapers || Download paper

  93. Reference Pricing and Price Negotiations for Innovative New Drugs. (2013). Gandjour, Afschin.
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:31:y:2013:i:1:p:11-14.

    Full description at Econpapers || Download paper

  94. Eliminating the U.S. drug lag: Implications for drug safety. (2013). Olson, Mary.
    In: Journal of Risk and Uncertainty.
    RePEc:kap:jrisku:v:47:y:2013:i:1:p:1-30.

    Full description at Econpapers || Download paper

  95. Diffusion of Pharmaceuticals: Cross-Country Evidence of Anti-TNF drugs. (2013). Brekke, Kurt ; Dalen, Dag Morten ; Holms, Tor Helge.
    In: Discussion Paper Series in Economics.
    RePEc:hhs:nhheco:2013_007.

    Full description at Econpapers || Download paper

  96. Drug launch timing and international reference pricing. (2013). Jelovac, Izabela ; Houy, Nicolas.
    In: Working Papers.
    RePEc:hal:wpaper:halshs-00782179.

    Full description at Econpapers || Download paper

  97. Drug launch timing and international reference pricing. (2013). Jelovac, Izabela ; Houy, Nicolas.
    In: Working Papers.
    RePEc:gat:wpaper:1301.

    Full description at Econpapers || Download paper

  98. Generic-branded drug competition and the price for pharmaceuticals in procurement auctions. (2013). Barbosa, Klenio ; Arvate, Paulo ; Barbosa, Klenio de Souza, ; Gambardella, Dante .
    In: Textos para discussão.
    RePEc:fgv:eesptd:333.

    Full description at Econpapers || Download paper

  99. PARALLEL IMPORTS AND INNOVATION IN AN EMERGING ECONOMY: THE CASE OF INDIAN PHARMACEUTICALS. (2012). Naghavi, Alireza ; Mantovani, Andrea.
    In: Health Economics.
    RePEc:wly:hlthec:v:21:y:2012:i:11:p:1286-1299.

    Full description at Econpapers || Download paper

  100. Pharmaceutical Innovation and Parallel Trade. (2012). Valletti, Tommaso ; Bennato, Anna Rita.
    In: Working Paper series, University of East Anglia, Centre for Competition Policy (CCP).
    RePEc:uea:ueaccp:2012_09.

    Full description at Econpapers || Download paper

  101. Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010. (2012). Dubois, Pierre ; Berndt, Ernst .
    In: TSE Working Papers.
    RePEc:tse:wpaper:25744.

    Full description at Econpapers || Download paper

  102. Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010. (2012). Dubois, Pierre ; Berndt, Ernst .
    In: IDEI Working Papers.
    RePEc:ide:wpaper:25732.

    Full description at Econpapers || Download paper

  103. Negative Effects of Intellectual Property Protection: The unusual suspects?. (2012). Kazutaka, TAKECHI .
    In: Discussion papers.
    RePEc:eti:dpaper:12057.

    Full description at Econpapers || Download paper

  104. I Farmaci Oncologici in Italia: innovazione e sostenibilità economica. (2012). SALERNO, Nicola ; Riccaboni, Massimo ; Pammolli, Fabio.
    In: Working Papers CERM.
    RePEc:ern:wpaper:02-2012.

    Full description at Econpapers || Download paper

  105. Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010. (2012). Dubois, Pierre ; Berndt, Ernst R.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:9140.

    Full description at Econpapers || Download paper

  106. Co-Payment Exemptions and Reference Prices: an Empirical Study of Pharmaceutical Prices in Germany. (2011). Suppliet, Moritz ; Herr, Annika.
    In: Health, Econometrics and Data Group (HEDG) Working Papers.
    RePEc:yor:hectdg:11/18.

    Full description at Econpapers || Download paper

  107. External referencing and pharmaceutical price negotiation. (2011). Olivella, Pau ; Jelovac, Izabela ; Marioso, Begoa Garcia .
    In: Health Economics.
    RePEc:wly:hlthec:v:20:y:2011:i:6:p:737-756.

    Full description at Econpapers || Download paper

  108. Innovation, loyalty and generic competition in pharmaceutical markets. (2011). Juarez-Castello, Carmelo ; Rodriguez-Ibeas, Roberto ; Antoanzas, Fernando.
    In: SERIEs: Journal of the Spanish Economic Association.
    RePEc:spr:series:v:2:y:2011:i:1:p:75-95.

    Full description at Econpapers || Download paper

  109. The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors. (2011). Vandoros, Sotiris ; Kanavos, Panos ; von der Schulenburg, Fritz .
    In: Health Economics Review.
    RePEc:spr:hecrev:v:1:y:2011:i:1:p:1-8:10.1186/2191-1991-1-18.

    Full description at Econpapers || Download paper

  110. Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry. (2011). Higgins, Matthew ; Chatterjee, Chirantan ; Branstetter, Lee G..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:17188.

    Full description at Econpapers || Download paper

  111. Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement. (2011). Towse, Adrian ; Danzon, Patricia ; Mulcahy, Andrew W..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:17174.

    Full description at Econpapers || Download paper

  112. The battle for patent rights in plant biotechnology: evidence from opposition fillings. (2011). Schneider, Cédric.
    In: The Journal of Technology Transfer.
    RePEc:kap:jtecht:v:36:y:2011:i:5:p:565-579.

    Full description at Econpapers || Download paper

  113. Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment. (2011). Straume, Odd Rune ; Brekke, Kurt ; Holmas, Tor Helge .
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:95:y:2011:i:7:p:624-638.

    Full description at Econpapers || Download paper

  114. Regulatory policy and the location of bio-pharmaceutical foreign direct investment in Europe. (2011). Koenig, Pamina ; MacGarvie, Megan.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:30:y:2011:i:5:p:950-965.

    Full description at Econpapers || Download paper

  115. The global entry of new pharmaceuticals: A joint investigation of launch window and price. (2011). Verniers, Isabel ; Croux, Christophe ; Stremersch, Stefan .
    In: International Journal of Research in Marketing.
    RePEc:eee:ijrema:v:28:y:2011:i:4:p:295-308.

    Full description at Econpapers || Download paper

  116. Explaining Early Adoption on New Medicines: Regulation, Innovation and Scale. (2011). Costa-i-Font, Joan ; McGuire, Alistair ; Varol, Nebibe ; Joan Costa-i-Font, ; Joan Costa-i-Font, .
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_3459.

    Full description at Econpapers || Download paper

  117. Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition? Evidence from the OECD, 1999-2008. (2011). Costa-i-Font, Joan ; McGuire, Alistair ; Varol, Nebibe ; Joan Costa-i-Font, ; Joan Costa-i-Font, .
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_3441.

    Full description at Econpapers || Download paper

  118. Strategic Responses to Parallel Trade. (2011). Kyle, Margaret.
    In: The B.E. Journal of Economic Analysis & Policy.
    RePEc:bpj:bejeap:v:11:y:2011:i:2:n:2.

    Full description at Econpapers || Download paper

  119. Parallel trade and its impact on incentives to invest in product quality. (2011). Reverberi, Pierfrancesco ; Matteucci, Giorgio.
    In: DIS Technical Reports.
    RePEc:aeg:wpaper:2011-5.

    Full description at Econpapers || Download paper

  120. Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry. (2010). Appelt, Silvia .
    In: Discussion Paper Series of SFB/TR 15 Governance and the Efficiency of Economic Systems.
    RePEc:trf:wpaper:357.

    Full description at Econpapers || Download paper

  121. Pricing and Reimbursement in U.S. Pharmaceutical Markets. (2010). Newhouse, Joseph ; Berndt, Ernst R..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:16297.

    Full description at Econpapers || Download paper

  122. Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry. (2010). Appelt, Silvia .
    In: Discussion Papers in Economics.
    RePEc:lmu:muenec:11476.

    Full description at Econpapers || Download paper

  123. Pricing and Reimbursement in U.S. Pharmaceutical Markets. (2010). Newhouse, Joseph ; Berndt, Ernst R..
    In: Scholarly Articles.
    RePEc:hrv:hksfac:4450127.

    Full description at Econpapers || Download paper

  124. Do international launch strategies of pharmaceutical corporations respond to changes in the regulatory environment?. (2010). Costa-i-Font, Joan ; McGuire, Alistair ; Varol, Nebibe ; Joan Costa-i-Font, ; Joan Costa-i-Font, .
    In: LSE Research Online Documents on Economics.
    RePEc:ehl:lserod:29972.

    Full description at Econpapers || Download paper

  125. Patent Incentives, Technology Markets, and Public-Private Bio-Medical Innovation Networks in Brazil. (2010). Ryan, Michael P..
    In: World Development.
    RePEc:eee:wdevel:v:38:y:2010:i:8:p:1082-1093.

    Full description at Econpapers || Download paper

  126. Reference Pricing, Competition, and Pharmaceutical Expenditures: Theory and Evidence from a Natural Experiment. (2010). Straume, Odd Rune ; Brekke, Kurt ; Holms, Tor Helge.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_3258.

    Full description at Econpapers || Download paper

  127. Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy. (2010). Cockburn, Iain ; Stern, Scott.
    In: Capitalism and Society.
    RePEc:bpj:capsoc:v:5:y:2010:i:1:n:1.

    Full description at Econpapers || Download paper

  128. THE DETERMINANTS OF INTERNATIONAL PATENTING FOR NINE AGRICULTURAL BIOTECHNOLOGY FIRMS -super-*. (2010). CHAN, PHOEBE H..
    In: Journal of Industrial Economics.
    RePEc:bla:jindec:v:58:y:2010:i:2:p:247-278.

    Full description at Econpapers || Download paper

  129. Regulatory Exploitation and Management Changes: Upcoding in the Hospital Industry. (2009). Dranove, David ; Dafny, Leemore .
    In: Journal of Law and Economics.
    RePEc:ucp:jlawec:v:52:y:2009:i:2:p:223-250.

    Full description at Econpapers || Download paper

  130. Sales Growth of New Pharmaceuticals Across the Globe: The Role of Regulatory Regimes. (2009). Lemmens, Aurelie ; Stremersch, Stefan .
    In: Marketing Science.
    RePEc:inm:ormksc:v:28:y:2009:i:4:p:690-708.

    Full description at Econpapers || Download paper

  131. Regulatory policy and the location of bio-pharmaceutical FDI in Europe. (2009). Koenig, Pamina ; MacGarvie, Megan.
    In: Working Papers.
    RePEc:hal:wpaper:halshs-00566800.

    Full description at Econpapers || Download paper

  132. Regulatory policy and the location of bio-pharmaceutical FDI in Europe. (2009). Koenig, Pamina ; MacGarvie, Megan.
    In: PSE Working Papers.
    RePEc:hal:psewpa:halshs-00566800.

    Full description at Econpapers || Download paper

  133. Assessing the Impact of Global Price Interdependencies. (2008). Richter, Anke .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:26:y:2008:i:8:p:649-659.

    Full description at Econpapers || Download paper

  134. Effects of Regulation on Drug Launch and Pricing in Interdependent Markets. (2008). Danzon, Patricia ; Epstein, Andrew J..
    In: NBER Working Papers.
    RePEc:nbr:nberwo:14041.

    Full description at Econpapers || Download paper

  135. External referencing and pharmaceutical price negotiation. (2008). Olivella, Pau ; Jelovac, Izabela ; Marioso, Begoa Garcia .
    In: Working Papers.
    RePEc:gat:wpaper:0815.

    Full description at Econpapers || Download paper

  136. International Strategic Alliances for Local Market Entry: Direct Launches versus Marketing Alliances in Pharmaceuticals. (2008). Kazutaka, TAKECHI .
    In: Discussion papers.
    RePEc:eti:dpaper:08022.

    Full description at Econpapers || Download paper

  137. Sales Growth of New Pharmaceuticals Across the Globe: The Role of Regulatory Regimes. (2008). Stremersch, Stefan ; Lemmens, A..
    In: ERIM Report Series Research in Management.
    RePEc:ems:eureri:12340.

    Full description at Econpapers || Download paper

  138. Strategic procurement, openness and market structure. (2008). Levine, Paul ; Garcia-Alonso, Maria ; García-Alonso, María D. C., .
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:26:y:2008:i:5:p:1180-1190.

    Full description at Econpapers || Download paper

  139. Strategic Responses to Parallel Trade. (2007). Kyle, Margaret.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:12968.

    Full description at Econpapers || Download paper

  140. Importation and Innovation. (2006). Lichtenberg, Frank.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:12539.

    Full description at Econpapers || Download paper

  141. Regulatory Exploitation and the Market for Corporate Controls. (2006). Dranove, David ; Dafny, Leemore .
    In: NBER Working Papers.
    RePEc:nbr:nberwo:12438.

    Full description at Econpapers || Download paper

  142. Strategic Procurement, Openness and Market Structure. (2005). Levine, Paul ; Garcia-Alonso, Maria.
    In: Studies in Economics.
    RePEc:ukc:ukcedp:0503.

    Full description at Econpapers || Download paper

  143. Strategic Procurement, Openness and Market Structure. (2004). Levine, Paul ; Garcia-Alonso, Maria.
    In: School of Economics Discussion Papers.
    RePEc:sur:surrec:0904.

    Full description at Econpapers || Download paper

References

References cited by this document

    This document has not been processed yet.

    You may help us by submiting the list of references

Cocites

Documents in RePEc which have cited the same bibliography

          This document has not co-citation data yet.

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2024-12-15 16:59:15 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated October, 6 2023. Contact: CitEc Team.